Lakshmikumaran And Sridharan Advised Krsnaa Diagnostics On Stake Purchase In Apulki Healthcare
Lakshmikumaran and Sridharan advised Krsnaa Diagnostics Limited, a listed entity on its acquisition of 23.35% stake in
Lakshmikumaran And Sridharan Advised Krsnaa Diagnostics On Stake Purchase In Apulki Healthcare
Lakshmikumaran and Sridharan advised Krsnaa Diagnostics Limited, a listed entity on its acquisition of 23.35% stake in Apulki Healthcare Private Limited. Apulki specialises in operating cancer and cardiac care hospitals in public-private partnership (PPP) mode.
The firm’s role included conducting legal due diligence on Apulki, drafting and review of transaction documents, and strategic advisory on tax implications.
The corporate due diligence team at Lakshmikumaran and Sridharan consisted of Noorul Hassan, Partner, Shipra Verma, Principal Associate, Aishwarya Narasimhan, Associate and Krishna Chandak, Consultant.
Additionally, Sameer Avasarala, Principal Associate and Aryashree Kunhambu, Associate assisted with intellectual property and data protection aspects of the due diligence.
The transaction team was led by Noorul Hassan along with Shipra Verma and Kumar Panda, Principal Associate. Direct tax advisory was provided by Mr. Sudin Sabnis, Partner, Lokesh Gandhi, Associate and Deah Kapoor, Consultant.”